Published in J Virol on June 20, 2012
MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a. J Virol (2014) 0.83
Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc Natl Acad Sci U S A (2013) 0.83
Human cytomegalovirus riding the cell cycle. Med Microbiol Immunol (2015) 0.80
Cyclin A degradation by primate cytomegalovirus protein pUL21a counters its innate restriction of virus replication. PLoS Pathog (2013) 0.79
PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathog (2014) 0.78
Synthetic lethal mutations in the cyclin A interface of human cytomegalovirus. PLoS Pathog (2017) 0.75
Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5. PLoS Pathog (2016) 0.75
The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication. PLoS Pathog (2017) 0.75
Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol (2001) 3.86
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol (2001) 3.50
A p53-dependent checkpoint pathway prevents rereplication. Mol Cell (2003) 3.42
Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet (2006) 3.26
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Cyclin E in normal and neoplastic cell cycles. Oncogene (2005) 3.16
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A (1996) 3.16
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61
Cyclin A in cell cycle control and cancer. Cell Mol Life Sci (2002) 2.49
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol (1996) 2.41
Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol (1998) 2.18
Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell (2009) 2.05
The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev (2007) 2.03
Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science (2008) 1.99
Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol (2004) 1.96
The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol (2000) 1.92
Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci U S A (2004) 1.90
Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol (2003) 1.87
Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits. Mol Biol Cell (1992) 1.85
Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog (2009) 1.82
A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog (2010) 1.82
Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A (2002) 1.77
Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J Virol (1994) 1.73
High-resolution human cytomegalovirus transcriptome. Proc Natl Acad Sci U S A (2011) 1.67
Cyclin E. Int J Biochem Cell Biol (2004) 1.64
Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Mol Biol Cell (2002) 1.62
A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 1.57
A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A (2006) 1.43
The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology (1997) 1.40
The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem (1998) 1.39
Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J Virol (2009) 1.37
Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells. Mol Cell (2008) 1.32
SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol (2004) 1.28
The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J (2001) 1.25
Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation. Mol Cell (2011) 1.21
Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol (2004) 1.20
Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J Virol (2002) 1.19
Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest. J Biol Chem (1999) 1.17
Human cytomegalovirus DNA replication requires transcriptional activation via an IE2- and UL84-responsive bidirectional promoter element within oriLyt. J Virol (2004) 1.16
Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep (2003) 1.16
The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression. Nucleic Acids Res (1993) 1.15
Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol (2008) 1.12
Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication. J Virol (2003) 1.11
Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol (2011) 1.09
Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol (2008) 1.09
Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues. Biochem Pharmacol (2000) 1.08
Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol (1998) 1.05
Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection. J Virol (2004) 1.04
Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response. J Virol (2005) 1.04
Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol (2011) 1.03
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog (2010) 1.00
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
Complex alternative processing of human cytomegalovirus UL37 pre-mRNA. J Gen Virol (2003) 0.98
Established and novel Cdk/cyclin complexes regulating the cell cycle and development. Results Probl Cell Differ (2011) 0.97
The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J Virol (2010) 0.97
Human cytomegalovirus: host immune modulation by the viral US3 gene. Int J Biochem Cell Biol (2008) 0.97
Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J Virol (2008) 0.95
Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociation. Cell Cycle (2005) 0.94
Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase. Arch Virol (1998) 0.94
Cyclin A-CDK activity during G1 phase impairs MCM chromatin loading and inhibits DNA synthesis in mammalian cells. Cell Cycle (2008) 0.91
The S phase of the cell cycle and its perturbation by human cytomegalovirus. Rev Med Virol (2007) 0.91
Studies on the in vitro phosphorylation of HSSB-p34 and -p107 by cyclin-dependent kinases. Cyclin-substrate interactions dictate the efficiency of phosphorylation. J Biol Chem (1996) 0.91
Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts. J Virol (2010) 0.91
Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol (2010) 0.90
Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology (2007) 0.90
General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism. J Gen Virol (2011) 0.87
Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells. Acta Microbiol Immunol Hung (2005) 0.87
Fomivirsen for the treatment of cytomegalovirus retinitis. Am J Ophthalmol (2002) 0.87
Convergence of RNA cis elements and cellular polyadenylation factors in the regulation of human cytomegalovirus UL37 exon 1 unspliced RNA production. J Virol (2003) 0.86
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods (2011) 0.83
A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form. J Virol (2006) 0.82
RNase P ribozyme as an antiviral agent against human cytomegalovirus. Methods Mol Biol (2004) 0.76
The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew Chem Int Ed Engl (2011) 4.39
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia. J Clin Oncol (2011) 1.61
Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew Chem Int Ed Engl (2012) 1.34
Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol (2004) 1.20
Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep (2003) 1.16
TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies. Hum Mutat (2002) 1.13
A role for E2F6 in the restriction of male-germ-cell-specific gene expression. Curr Biol (2005) 1.04
Impact of pre-analytical handling on bone marrow mRNA gene expression. Br J Haematol (2004) 1.02
HuSiDa--the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells. Nucleic Acids Res (2005) 1.02
Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog (2010) 1.00
Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling. J Virol (2006) 1.00
Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J Virol (2008) 0.95
Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociation. Cell Cycle (2005) 0.94
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res (2006) 0.93
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. J Biol Chem (2006) 0.92
Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells. J Gen Virol (2003) 0.90
General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism. J Gen Virol (2011) 0.87
Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells. Cancer Res (2006) 0.84
Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. J Neurooncol (2007) 0.83
Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc Natl Acad Sci U S A (2013) 0.83
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia. Blood (2010) 0.78
Use of 5-ethynyl-2'-deoxyuridine labelling and flow cytometry to study cell cycle-dependent regulation of human cytomegalovirus gene expression. Methods Mol Biol (2014) 0.77
Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia. Blood (2003) 0.75